OMER short interest
Omeros Corporation · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 11,382,531 |
|---|---|
| Change vs prior report | -1,109,045 (-8.9%) |
| Change over six months | -33.3% |
| Days to cover | 6.95 (sector: 3.78) |
| Average daily volume | 1,638,478 |
| Rank in Healthcare | #256 of 922 by days to cover |
OMER short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 11,382,531 | -8.9% | 6.95 | 1,638,478 |
| 2026-09-15 | 12,491,576 | -2.1% | 9.31 | 1,341,022 |
| 2026-08-31 | 12,758,406 | -12.8% | 7.30 | 1,747,098 |
| 2026-08-14 | 14,639,133 | -5.1% | 4.91 | 2,981,819 |
| 2026-07-31 | 15,420,416 | +2.2% | 9.87 | 1,561,802 |
| 2026-07-15 | 15,092,070 | -0.3% | 11.85 | 1,273,680 |
| 2026-06-30 | 15,136,140 | -16.4% | 5.61 | 2,695,791 |
| 2026-06-15 | 18,103,605 | +11.3% | 8.44 | 2,145,416 |
| 2026-05-29 | 16,271,790 | +2.1% | 9.05 | 1,798,109 |
| 2026-05-15 | 15,940,028 | +0.9% | 10.84 | 1,470,074 |
| 2026-04-30 | 15,789,527 | -6.6% | 13.09 | 1,206,519 |
| 2026-04-15 | 16,900,273 | -1.0% | 11.43 | 1,478,463 |
| 2026-03-31 | 17,069,802 | -1.4% | 18.78 | 908,718 |
| 2026-03-13 | 17,312,128 | +0.1% | 22.18 | 780,372 |
| 2026-02-27 | 17,289,620 | -3.7% | 21.18 | 816,280 |
| 2026-02-13 | 17,959,196 | +1.7% | 17.68 | 1,015,590 |
| 2026-01-30 | 17,661,898 | +7.5% | 10.44 | 1,692,353 |
| 2026-01-15 | 16,429,140 | +24.0% | 4.67 | 3,516,886 |
| 2025-12-31 | 13,247,185 | -4.8% | 2.60 | 5,093,923 |
| 2025-12-15 | 13,919,634 | +4.3% | 9.47 | 1,470,045 |
| 2025-11-28 | 13,350,021 | -0.0% | 7.80 | 1,711,959 |
| 2025-11-14 | 13,353,498 | +9.9% | 7.79 | 1,715,015 |
| 2025-10-31 | 12,155,081 | -5.7% | 4.20 | 2,896,541 |
| 2025-10-15 | 12,891,428 | +1.8% | 1.06 | 12,206,313 |
| 2025-09-30 | 12,660,129 | -6.2% | 12.38 | 1,022,800 |
import finzdata as yf
yf.Ticker("OMER").short_interest # every report since 2017
yf.Client().short_interest(["OMER"], start="2018-01-01")Healthcare short interest · OMER price history · Who owns OMER · All short interest